Motesanib

DRUG2 trials

Sponsors

Sidney Kimmel Cancer Center at Thomas Jefferson University, Takeda

Conditions

Breast CancerCarcinoma, Non-Small-Cell LungMetastatic Breast CancerStage IV Breast Cancer

Phase 1

Investigational Drug in Combination With Two Chemotherapy Drugs in Women With Locally Recurrent or Metastatic Breast Cancer

WithdrawnNCT01349088

Sidney Kimmel Cancer Center at Thomas Jefferson UniversityBreast Cancer, Metastatic Breast Cancer, Stage IV Breast Cancer

Start: 2013-12-31End: 2018-09-30Updated: 2025-05-02

Phase 3

Study of Motesanib (AMG 706) in Combination With Paclitaxel and Carboplatin for Advanced Non-Squamous Non-Small Cell Lung Cancer

TerminatedNCT02629848

TakedaCarcinoma, Non-Small-Cell Lung

Start: 2012-07-31End: 2015-03-31Updated: 2015-12-14